AI assistant
HEALTHEQUITY, INC. — Director's Dealing 2021
Jun 22, 2021
30722_dirs_2021-06-22_a04876aa-1b03-40ee-9ebe-6fd4e78e8819.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HEALTHEQUITY, INC. (HQY)
CIK: 0001428336
Period of Report: 2021-06-21
Reporting Person: MOTT DARCY G (Special Advisor)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-06-21 | Common Stock | M | 10000 | $14.00 | Acquired | 85052 | Direct |
| 2021-06-21 | Common Stock | S | 2796 | $76.6174 | Disposed | 82256 | Direct |
| 2021-06-21 | Common Stock | S | 3204 | $77.6754 | Disposed | 79052 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-06-21 | Stock Option (right to buy) | $14 | M | 10000 | Disposed | 2024-07-30 | Common Stock (10000) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $25.39 | 2025-03-26 | Common Stock (25000) | 25000 | Direct |
| Stock Option (right to buy) | $41.28 | 2027-03-27 | Common Stock (19897) | 19897 | Direct |
| Stock Option (right to buy) | $61.72 | 2028-03-27 | Common Stock (14228) | 14228 | Direct |
| Stock Option (right to buy) | $73.61 | 2029-03-26 | Common Stock (15337) | 15337 | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.19 to $77.15, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) and (3) of this Form 4.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.19 to $78.01, inclusive.
F4: The option is immediately exercisable.
F5: The option is exercisable as to 10,671 shares. The remaining 3,557 options vest on March 27, 2022.
F6: The option is exercisable as to 7,669 shares. The remaining options vest as to 3,834 shares on each of March 27, 2022 and 2023.